Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Zosano Pharma Reports First Quarter 2019 Financial Results
-
Zosano Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
Pre-Open Stock Movers 04/23: (GNC) (HAS) (TWTR) Higher; (MBRX) (WAT) (HRL) Lower (more...)
-
After-Hours Movers 04/22: (CMRE) (WHR) (ZSAN) Higher; (GRTS) (RMBS) (more...)
-
Cantor Fitzgerald Starts Zosano Pharma (ZSAN) at Overweight
-
Zosano Pharma (ZSAN) Prices Public Offering of Common Stock for Gross Proceeds of $17.5 Million
-
Zosano Announces Pricing of Public Offering of Common Stock
-
Zosano Pharma (ZSAN) Commences Public Offering of Common Stock
-
Zosano Pharma Announces Proposed Public Offering of Common Stock
-
Zosano Pharma to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Zosano Pharma to Present at the Cantor Fitzgerald Inaugural Healthcare Conference